BioPharm America

By |September, 2016|

BioPharm America 2017, Boston, MA, USA, September 26–27, 2017


Please meet us at the 2017 BioPharm America in Boston. BioPharm America is the only event in North America based on the same reputable formula as European […]

BIO-Europe

By |August, 2016|

BIO-Europe 2017, Berlin, Germany, November 6-8, 2017


Please meet us at the 2017 International Partnering Conference in Berlin, Germany. BIO-Europe is Europe’s largest partnering conference, serving the global biotechnology industry. The conference annually attracts international leaders […]

Deal supported by Xplico

By |July, 2016|

LEO Pharma enters biologics through strategic partnership with AstraZeneca.

Funding round supported by Xplico

By |June, 2016|

AFFiRiS AG successfully raises €10m equity financing

Acquisition supported by Xplico

By |June, 2016|

Targovax and Oncos Therapeutics join forces to create a Nordic leader within immuno-oncology.

Deal supported by Xplico

By |May, 2016|

4SC enters into licensing and development partnership with Link Health for the cancer compound 4SC 205 in China.

Deal supported by Xplico

By |February, 2016|

PharmaMar and Specialised Therapeutics Asia sign licensing and marketing agreement for APLIDIN® (plitidepsin) covering several Asian countries.

Deal supported by Xplico

By |January, 2016|

Baxalta and Symphogen Establish Strategic Collaboration to Accelerate Innovation in Immuno-Oncology.

Deal supported by Xplico

By |December, 2015|

Bavarian Nordic Enters Licensing and Collaboration Agreement with Janssen for MVA-BN® in the Development of a Therapeutic HPV Vaccine.

Deal supported by Xplico

By |November, 2015|

LEO Pharma to acquire global dermatology portfolio from Astellas.